Alkaline Phosphatase Elevation in Eating Disorders
Alkaline phosphatase (ALP) elevation is a recognized biochemical abnormality in eating disorders, particularly more common in bulimia nervosa than anorexia nervosa, and should be evaluated as part of the comprehensive metabolic panel recommended for all patients with suspected eating disorders 1.
Initial Evaluation
When encountering a patient with an eating disorder and elevated ALP, the APA 2023 guidelines mandate specific laboratory assessment:
- Obtain a comprehensive metabolic panel including liver enzymes (which encompasses ALP) as part of the initial workup for any patient with a possible eating disorder 1
- This testing is a 1C recommendation, meaning it should be done routinely regardless of clinical presentation
The biochemical profile in eating disorders shows:
- Elevated ALP occurs in both anorexia nervosa and bulimia nervosa, but is significantly more common in bulimia 2
- Other common abnormalities include elevated AST, ALT, total CO2, calcium, albumin, and cholesterol, with decreased potassium, chloride, and phosphate 2
Differential Diagnosis and Further Workup
Do not assume the ALP elevation is benign simply because the patient has an eating disorder. The 2018 Gut guidelines on abnormal liver tests provide the framework:
- Perform a standard liver aetiology screen including abdominal ultrasound, hepatitis B surface antigen, hepatitis C antibody, anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins, and simultaneous ferritin with transferrin saturation 3
- Obtain ALP isoenzyme fractionation to determine if the elevation is from liver, bone, or intestinal sources 4
Critical Pitfall to Avoid
In patients with persistently elevated ALP of unclear etiology after initial workup, malignancy is the most common cause (57% of cases), particularly infiltrative intrahepatic malignancy or bony metastasis 5. This is especially important because 47% of patients with unexplained isolated ALP elevation died within an average of 58 months 5.
Clinical Context Matters
The ALP elevation in eating disorders likely relates to:
- Malnutrition and calorie depletion (the most common cause of persistent low or abnormal ALP patterns in eating disorder populations) 6
- Hepatic steatosis from refeeding or metabolic derangements
- Bone turnover abnormalities from nutritional deficiencies
However, the extent of ALP abnormality does not necessarily indicate clinical significance - the specific clinical context determines this 3.
Management Approach
Address the underlying eating disorder as the primary intervention:
- For anorexia nervosa: Implement eating disorder-focused psychotherapy for adults (1B recommendation) or family-based treatment for adolescents with involved caregivers (1B recommendation), focusing on normalizing eating behaviors and weight restoration 1
- For bulimia nervosa: Initiate eating disorder-focused cognitive-behavioral therapy with consideration of fluoxetine 60 mg daily, either initially or if minimal response by 6 weeks (1C recommendation) 1
Monitor ALP serially during nutritional rehabilitation:
- ALP should normalize with successful treatment of the eating disorder and restoration of nutritional status
- Persistent elevation despite treatment warrants the full liver aetiology screen described above 3
Coordinate care through a multidisciplinary team incorporating medical, psychiatric, psychological, and nutritional expertise as mandated by APA guidelines 1.
Key Takeaway
While ALP elevation is an expected finding in eating disorders (especially bulimia), never attribute it solely to the eating disorder without proper evaluation. The combination of comprehensive metabolic panel monitoring (per eating disorder guidelines) and appropriate liver workup (per hepatology guidelines) ensures you don't miss serious underlying pathology, particularly malignancy in cases of persistent unexplained elevation.